U.S. Markets open in 58 mins.

Sunesis Pharmaceuticals, Inc. (SNSS)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.57-0.09 (-3.38%)
At close: 4:00PM EDT
People also watch
CYCCTHLDRPRXAEZSXOMA
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue2,5363,0615,734
Cost of Revenue---
Gross Profit2,5363,0615,734
Operating Expenses
Research Development22,88123,70127,665
Selling General and Administrative16,11518,66223,112
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-36,460-39,302-45,043
Income from Continuing Operations
Total Other Income/Expenses Net1583,5653,760
Earnings Before Interest and Taxes-36,302-35,737-41,283
Interest Expense1,7219391,719
Income Before Tax-38,023-36,676-43,002
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-38,023-36,676-43,002
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-38,023-36,676-43,002
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-38,023-36,676-43,002